Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07808697 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Moderna
49 trials monitored
See 3 trials at risk
This study will evaluate 2 dose levels of mRNA-1283 in participants ≥6 months to \<12 years to determine the optimal dose level per age group.
Trial Details
NCT Number NCT07808697
Lead Sponsor ModernaTX, Inc.
Conditions
(from sponsor)		 SARS-CoV-2
Related terms Coronavirus Infections, COVID-19, Virus Diseases
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov